Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinkun Zhang

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Crohn'S & Colitis|January 21, 2021
Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS StudySéverine Vermeire, Michael Chiorean, Julián Panés, et al.
Gastroenterology|November 13, 2019
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative ColitisWilliam J Sandborn, Laurent Peyrin-Biroulet, Jinkun Zhang, et al.
The European Respiratory Journal|August 9, 2019
Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trialFernando Torres, Harrison Farber, Arsen Ristic, et al.
Anticancer Research|July 9, 2011
Identification of polymorphisms associated with hypertriglyceridemia and prolonged survival induced by bexarotene in treating non-small cell lung cancerWen Luo, Nicholas J Schork, Keith B Marschke, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Crohn'S & Colitis|January 21, 2021
Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS StudySéverine Vermeire, Michael Chiorean, Julián Panés, et al.
Gastroenterology|November 13, 2019
Efficacy and Safety of Etrasimod in a Phase 2 Randomized Trial of Patients With Ulcerative ColitisWilliam J Sandborn, Laurent Peyrin-Biroulet, Jinkun Zhang, et al.
The European Respiratory Journal|August 9, 2019
Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trialFernando Torres, Harrison Farber, Arsen Ristic, et al.
Anticancer Research|July 9, 2011
Identification of polymorphisms associated with hypertriglyceridemia and prolonged survival induced by bexarotene in treating non-small cell lung cancerWen Luo, Nicholas J Schork, Keith B Marschke, et al.
Pageof 4